Abiomed Inc (Abiomed) is a medical device company. It develops innovative heart pump technologies, including the Impella family, which provides temporary hemodynamic support for patients with severe coronary artery disease and heart failure. The company’s product portfolio includes the Impella CP, designed for high-risk PCI procedures and cardiogenic shock, and the Impella 5.5, offering full cardiac support for long-duration use. The Impella RP supports patients with right heart failure. Abiomed offers the Breethe OXY-1 System, a compact cardiopulmonary support device that oxygenates and pumps blood while enabling patient mobility. The company also offers Impella Connect, a cloud-based platform that allows healthcare teams to remotely monitor patient status. Abiomed is headquartered in Danvers, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abiomed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Abiomed Inc Company Overview
- Abiomed Inc Company Snapshot
- Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Abiomed Inc - Pipeline Analysis Overview
- Business Description
- Abiomed Inc - Key Facts
- Abiomed Inc - Major Products and Services
- Abiomed Inc Pipeline Products by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc Pipeline Products Overview
- AbioCor II
- AbioCor II Product Overview
- Artificial Intelligence Algorithm
- Artificial Intelligence Algorithm Product Overview
- Artificial Intelligence Algorithm Clinical Trial
- Expandable Sheath - Heart Failure
- Expandable Sheath - Heart Failure Product Overview
- Impecmo
- Impecmo Product Overview
- Impella BTR
- Impella BTR Product Overview
- Impella BTR Clinical Trial
- Impella ECP
- Impella ECP Product Overview
- Impella ECP Clinical Trial
- Impella XC
- Impella XC Product Overview
- Impella XR Sheath With Impella CP
- Impella XR Sheath With Impella CP Product Overview
- Laminar Left Atrial Appendage Closure System
- Laminar Left Atrial Appendage Closure System Product Overview
- Laminar Left Atrial Appendage Closure System Clinical Trial
- Next Generation Impella CP - STEMI
- Next Generation Impella CP - STEMI Product Overview
- Next Generation Impella CP - STEMI Clinical Trial
- Symphony Heart Pump
- Symphony Heart Pump Product Overview
- Abiomed Inc - Key Competitors
- Abiomed Inc - Key Employees
- Abiomed Inc - Key Employee Biographies
- Abiomed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Abiomed Inc, Recent Developments
- Dec 22, 2025: Blood Pump Controller Correction: Abiomed Updates Use Instructions for Automated Impella Controllers
- Oct 28, 2025: Abiomed Receives Additional 510(K) Clearance For 14Fr Low Profile Introducer Set
- Oct 24, 2025: Johnson & Johnson MedTech Highlights Newest Impella Heart Pump and Long-Term Survival Data at TCT 2025
- Oct 10, 2025: Alert: Automated Impella Controller Correction due to Cybersecurity Issue from Abiomed
- Sep 23, 2025: Early Alert: Automated Impella Controller Purge Retainer Fixation Issue from Abiomed
- Aug 31, 2025: New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump
- Jul 01, 2025: Early Alert: Blood Pump Controller Issue from Abiomed
- Mar 27, 2025: Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
- Feb 14, 2025: Heart Pump Recall: Abiomed Updates Use Instructions for Impella RP with SmartAssist and Impella RP Flex with SmartAssist Due to A Risk That the Tip of Guidewires or Other Medical Devices May Come into Contact with The Impella Pump During Insertion, A
- Dec 12, 2024: U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
- Abiomed Inc Pipeline Products by Equipment Type
- Abiomed Inc Pipeline Products by Indication
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc, Key Facts
- Abiomed Inc, Major Products and Services
- Abiomed Inc Number of Pipeline Products by Development Stage
- Abiomed Inc Pipeline Products Summary by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
- Abiomed Inc Ongoing Clinical Trials Summary
- AbioCor II - Product Status
- AbioCor II - Product Description
- Artificial Intelligence Algorithm - Product Status
- Artificial Intelligence Algorithm - Product Description
- Artificial Intelligence Algorithm - Abiomed IMPELLA-RT-DAQ - Impella Real Time Data Acquisition
- Expandable Sheath - Heart Failure - Product Status
- Expandable Sheath - Heart Failure - Product Description
- Impecmo - Product Status
- Impecmo - Product Description
- Impella BTR - Product Status
- Impella BTR - Product Description
- Impella BTR - Use of the Impella BTR in Patients with Heart Failure: An Early Feasibility Study
- Impella ECP - Product Status
- Impella ECP - Product Description
- Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention: An Early Feasibility Study
- Impella XC - Product Status
- Impella XC - Product Description
- Impella XR Sheath With Impella CP - Product Status
- Impella XR Sheath With Impella CP - Product Description
- Laminar Left Atrial Appendage Closure System - Product Status
- Laminar Left Atrial Appendage Closure System - Product Description
- Laminar Left Atrial Appendage Closure System - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
- Next Generation Impella CP - STEMI - Product Status
- Next Generation Impella CP - STEMI - Product Description
- Next Generation Impella CP - STEMI - Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
- Symphony Heart Pump - Product Status
- Symphony Heart Pump - Product Description
- Abiomed Inc, Key Employees
- Abiomed Inc, Key Employee Biographies
- Abiomed Inc, Subsidiaries
- Glossary
- Abiomed Inc Pipeline Products by Equipment Type
- Abiomed Inc Pipeline Products by Development Stage
- Abiomed Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Getinge AB
- Abbott Laboratories
- LivaNova Plc
- Boston Scientific Corp
- Berlin Heart GmbH
- Jarvik Heart Inc
- Medtronic Plc
- Edwards Lifesciences Corp
